Moonlake Immunotherapeutics Stock Three Year Return

MLTX Stock

USD 54.43 0.19 0.35%

MoonLake Immunotherapeutics fundamentals help investors to digest information that contributes to MoonLake Immunotherapeuti's financial success or failures. It also enables traders to predict the movement of MoonLake Stock. The fundamental analysis module provides a way to measure MoonLake Immunotherapeuti's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to MoonLake Immunotherapeuti stock.

Short Long Term Debt Total Total Assets

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

MoonLake Immunotherapeutics Company Three Year Return Analysis

MoonLake Immunotherapeuti's Tree Year Return shows the total annualized return generated from holding a fund or ETFs for the last three years. The return measure includes capital appreciation, losses, dividends paid, and all capital gains distributions. This return indicator is considered by many investors to be solid measures of fund mid-term performance.

Three Year Return

(Mean of Monthly Returns - 1)

X

100%

More About Three Year Return | All Equity Analysis

MoonLake Three Year Return Driver Correlations

Understanding the fundamental principles of building solid financial models for MoonLake Immunotherapeuti is extremely important. It helps to project a fair market value of MoonLake Stock properly, considering its historical fundamentals such as Three Year Return. Since MoonLake Immunotherapeuti's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of MoonLake Immunotherapeuti's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of MoonLake Immunotherapeuti's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Net Tangible Assets	Accounts Payable	Net Receivables	Deferred Long Term Liab	Net Invested Capital	Short Long Term Debt	Capital Stock	Net Working Capital	Property Plant Equipment	Capital Surpluse	Current Deferred Revenue
Total Assets		1.0	-0.98	-0.75	0.33	0.97	-0.17	-0.51	-0.7	-0.63	0.98	-0.94	0.98	-0.94	-0.74	0.97	0.88	-0.94	0.93
Total Stockholder Equity	1.0		-0.97	-0.71	0.28	0.96	-0.2	-0.47	-0.66	-0.59	0.97	-0.93	0.96	-0.93	-0.7	0.96	0.86	-0.93	0.92
Net Debt	-0.98	-0.97		0.86	-0.49	-1.0	0.01	0.67	0.79	0.73	-1.0	0.93	-1.0	0.93	0.82	-1.0	-0.95	0.93	-0.96
Retained Earnings	-0.75	-0.71	0.86		-0.74	-0.88	-0.28	0.95	0.92	0.9	-0.86	0.78	-0.87	0.78	0.93	-0.88	-0.91	0.78	-0.81
Total Liab	0.33	0.28	-0.49	-0.74		0.51	0.85	-0.87	-0.45	-0.43	0.5	-0.46	0.5	-0.46	-0.46	0.5	0.49	-0.46	0.47
Total Current Assets	0.97	0.96	-1.0	-0.88	0.51		0.01	-0.71	-0.81	-0.75	1.0	-0.94	1.0	-0.94	-0.84	1.0	0.94	-0.94	0.94
Short Term Debt	-0.17	-0.2	0.01	-0.28	0.85	0.01		-0.52	0.05	0.05	0.0	0.0	0.0	0.0	0.04	0.0	-0.02	0.0	0.01
Common Stock	-0.51	-0.47	0.67	0.95	-0.87	-0.71	-0.52		0.82	0.82	-0.68	0.61	-0.68	0.61	0.83	-0.7	-0.75	0.61	-0.62
Net Tangible Assets	-0.7	-0.66	0.79	0.92	-0.45	-0.81	0.05	0.82		0.99	-0.78	0.65	-0.79	0.65	0.99	-0.81	-0.92	0.65	-0.76
Accounts Payable	-0.63	-0.59	0.73	0.9	-0.43	-0.75	0.05	0.82	0.99		-0.71	0.62	-0.72	0.62	0.99	-0.75	-0.85	0.62	-0.67
Net Receivables	0.98	0.97	-1.0	-0.86	0.5	1.0	0.0	-0.68	-0.78	-0.71		-0.95	1.0	-0.95	-0.81	1.0	0.93	-0.95	0.94
Deferred Long Term Liab	-0.94	-0.93	0.93	0.78	-0.46	-0.94	0.0	0.61	0.65	0.62	-0.95		-0.95	1.0	0.74	-0.94	-0.78	1.0	-0.8
Net Invested Capital	0.98	0.96	-1.0	-0.87	0.5	1.0	0.0	-0.68	-0.79	-0.72	1.0	-0.95		-0.95	-0.82	1.0	0.93	-0.95	0.94
Short Long Term Debt	-0.94	-0.93	0.93	0.78	-0.46	-0.94	0.0	0.61	0.65	0.62	-0.95	1.0	-0.95		0.74	-0.94	-0.78	1.0	-0.8
Capital Stock	-0.74	-0.7	0.82	0.93	-0.46	-0.84	0.04	0.83	0.99	0.99	-0.81	0.74	-0.82	0.74		-0.85	-0.9	0.74	-0.75
Net Working Capital	0.97	0.96	-1.0	-0.88	0.5	1.0	0.0	-0.7	-0.81	-0.75	1.0	-0.94	1.0	-0.94	-0.85		0.94	-0.94	0.94
Property Plant Equipment	0.88	0.86	-0.95	-0.91	0.49	0.94	-0.02	-0.75	-0.92	-0.85	0.93	-0.78	0.93	-0.78	-0.9	0.94		-0.78	0.96
Capital Surpluse	-0.94	-0.93	0.93	0.78	-0.46	-0.94	0.0	0.61	0.65	0.62	-0.95	1.0	-0.95	1.0	0.74	-0.94	-0.78		-0.8
Current Deferred Revenue	0.93	0.92	-0.96	-0.81	0.47	0.94	0.01	-0.62	-0.76	-0.67	0.94	-0.8	0.94	-0.8	-0.75	0.94	0.96	-0.8

Click cells to compare fundamentals

Although Three Year Fund Return indicator can give a sense of overall fund mid-term potential, it is recommended to compare fund performances against other similar funds, ETFs, or market benchmarks for the same 3 year interval.

Competition

Predict MoonLake Immunotherapeuti

MoonLake Return On Tangible Assets

Return On Tangible Assets

(0.0718)

At this time, MoonLake Immunotherapeuti's Return On Tangible Assets are fairly stable compared to the past year.

Based on the latest financial disclosure, MoonLake Immunotherapeutics has a Three Year Return of 0.0%. This indicator is about the same for the Biotechnology average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).

MoonLake Three Year Return Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses MoonLake Immunotherapeuti's direct or indirect competition against its Three Year Return to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of MoonLake Immunotherapeuti could also be used in its relative valuation, which is a method of valuing MoonLake Immunotherapeuti by comparing valuation metrics of similar companies.

MoonLake Immunotherapeuti is currently under evaluation in three year return category among its peers.

MoonLake Immunotherapeuti ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, MoonLake Immunotherapeuti's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to MoonLake Immunotherapeuti's managers, analysts, and investors.

Environmental

Governance

Social

MoonLake Fundamentals

	Return On Equity	-0.17
	Return On Asset	-0.13
	Current Valuation	2.94 B
	Shares Outstanding	63.06 M
	Shares Owned By Insiders	15.22 %
	Shares Owned By Institutions	98.14 %
	Number Of Shares Shorted	8 M
	Price To Book	7.03 X
	EBITDA	(54.11 M)
	Net Income	(44.08 M)
	Cash And Equivalents	92.71 M
	Cash Per Share	2.51 X
	Total Debt	3.81 M
	Debt To Equity	0.01 %
	Current Ratio	25.51 X
	Book Value Per Share	7.74 X
	Cash Flow From Operations	(42.78 M)
	Short Ratio	36.06 X
	Earnings Per Share	(1.27) X
	Target Price	73.92
	Number Of Employees	50
	Beta	1.28
	Market Capitalization	3.43 B
	Total Asset	526.54 M
	Retained Earnings	(116.66 M)
	Working Capital	504.2 M
	Net Asset	526.54 M

About MoonLake Immunotherapeuti Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze MoonLake Immunotherapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of MoonLake Immunotherapeuti using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of MoonLake Immunotherapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C

Additional Tools for MoonLake Stock Analysis

When running MoonLake Immunotherapeuti's price analysis, check to measure MoonLake Immunotherapeuti's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MoonLake Immunotherapeuti is operating at the current time. Most of MoonLake Immunotherapeuti's value examination focuses on studying past and present price action to predict the probability of MoonLake Immunotherapeuti's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MoonLake Immunotherapeuti's price. Additionally, you may evaluate how the addition of MoonLake Immunotherapeuti to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC